We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
- Authors
Rinaldi, M; Crinò, L; Scagliotti, G V; Mosconi, A M; De Marinis, F; Gridelli, C; Selvaggi, G; Della Giulia, M; Darwish, S; Porrozzi, S; Novello, S; Cipri, A; Bartolucci, R; Calandri, C; Tonato, M
- Abstract
To explore a new schedule of gemcitabine-cisplatin (GP) combination therapy using two different cisplatin doses in patients with advanced non-small-cell lung cancer (NSCLC).
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Vol 11, Issue 10, p1295
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1023/a:1008334610955